Oral Appliances and Novel Device Therapies for Obstructive Sleep Apnea
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
This policy addresses coverage and coding for intraoral oral appliances and several novel device therapies (e.g., EPAP, oral pressure therapy, tongue stimulation, sleep-positioning trainers) for treatment of obstructive sleep apnea for Medicare Advantage and Commercial products.
No material clinical or coverage changes in this revision.
Coverage stance and medical necessity
Covered
Covered when ALL of the following are met:
Fitting, impressions, fabrication, initial fitting/education, and three follow-up visits are included in the global fee; member responsible for applicable DME cost-sharing; no prior authorization required
Not Covered / Not Medically Necessary
The following novel therapies are not covered or are considered not medically necessary due to insufficient evidence:
Specific HCPCS/K codes listed as not covered/not medically necessary (A7049, K1001, K1028, K1029, A7047); claims for services without assigned CPT/HCPCS codes should be filed with the unlisted DME code
Oral appliances used for conditions other than obstructive sleep apnea are excluded from coverage. Specifically, oral appliances for temporomandibular joint disease (TMJ) or bruxism are considered non-covered for all product lines. Over-the-counter (OTC) oral appliances for OSA are not covered because they have not demonstrated equivalence to custom-fitted devices. Devices intended solely to treat snoring when snoring is not associated with sleep apnea are also not covered. In addition, several device types with insufficient evidence to support clinical benefit are considered not covered or not medically necessary, including nasal expiratory positive airway pressure and oral pressure therapy devices, sleep-positioning trainers with vibration, daytime electrical stimulation of the tongue, and palate/mandible expansion devices.
This policy is informational and does not guarantee payment. Providers must verify member-specific benefits and eligibility with BCBSRI before providing services. If services are determined to be not medically necessary or are non-covered benefits, the member may be financially liable unless the member has been informed in advance and has agreed in writing to pay for the service.
The policy identifies the following novel or experimental device therapies as not covered or not medically necessary due to insufficient evidence: palate and mandible expansion devices, nasal expiratory positive airway pressure (EPAP), oral pressure therapy devices (for example, the Winx system), daytime electrical stimulation of the tongue (neuromuscular tongue stimulation), and sleep-positioning trainers that use vibration to prevent supine sleep.
Services determined to be not medically necessary under this policy are not assured payment and may be denied. Providers should confirm coverage and obtain any necessary authorizations and member agreement in writing when appropriate, because denials or non-covered determinations may result in member financial responsibility.
Codes and billing guidance
| A7049 | Expiratory positive airway pressure intranasal resistance valve (New code effective 4/01/2023) |
| K1001 | Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type |
| K1028 | Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle for the reduction of snoring and obstructive sleep apnea, controlled by phone application |
| K1029 | Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply |
| A7047 | Oral interface used with respiratory suction pump, each |
| CPT 95807-52 | referenced daytime, abbreviated cardio-respiratory sleep study (PAP-NAP) acclimation study |
What providers must do
Prior authorization
Prior authorization review is not required for oral appliance services.
Therapy sequencing
CPAP is considered first-line therapy for obstructive sleep apnea; oral appliances are an alternative for patients who are intolerant of or refuse CPAP. No formal step-therapy or prior authorization requiring trial of CPAP is imposed by this policy, but clinical judgment and member-specific benefit design may influence therapy selection.
Required provider actions and documentation
Fitting and fabrication of the oral appliance must be performed by qualified dental personnel (dentist or orthodontist) trained in overall oral health management. The global fee for the device is considered to include: initial evaluation, oral/dental impressions, fabrication of the appliance, initial fitting with patient education and instruction, and three follow-up visits after the patient begins device use. Providers may bill appropriate evaluation and management codes if a patient is found not to be an appropriate candidate following the initial consultation. A set of cephalometric X-rays (with and without the appliance) may be billed separately as diagnostic testing services. Replacement and repairs are covered per the Durable Medical Equipment Repair and Replacement policy; medical review/preauthorization is not required for repair/replacement when initial services did not require prior authorization. Members remain responsible for applicable DME copayments, coinsurance, and deductibles.
- Initial evaluation
- Oral/dental impressions
- Fabrication of the appliance
- Initial fitting, patient education, and device instruction
- Three follow-up visits once device use begins
- Cephalometric X-rays (with and without the appliance) may be billed separately
- Replacement and repairs follow Durable Medical Equipment Repair and Replacement policy
Member liability and denial risk
If services are determined to be not medically necessary or are non-covered benefits, claims may be denied and the member could be held financially liable unless the provider informed the member in advance and obtained written agreement to proceed at the member's expense. Verify member-specific benefits and eligibility with the provider call center prior to providing services; benefits are determined by the subscriber agreement or employer contract and will supersede this policy.
- Obtain written member agreement before providing non-covered services to avoid billing disputes
- Verify eligibility and benefits via provider call center prior to service
Clinical background
Obstructive sleep apnea (OSA) is characterized by repetitive collapse of the upper airway during sleep leading to intermittent hypoxemia and sleep fragmentation, which commonly presents with snoring and excessive daytime sleepiness and may have cardiovascular and pulmonary consequences. Management includes behavioral measures and first-line continuous positive airway pressure (CPAP); oral appliances (mandibular advancement or tongue-retaining devices) are an alternative for documented mild to moderate OSA and are furnished as durable medical equipment when provided by clinicians trained in oral sleep appliances. Several novel device therapies (for example, EPAP, oral pressure therapy, positional trainers, tongue stimulation, and palate/mandible expansion) have limited or insufficient evidence regarding their effects on health outcomes and therefore are considered investigational or not medically necessary in this policy.
Key definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.